
Joint Action
Is Methotrexate ready for clinical use? A discussion with Professor Robin Christensen and Dr Anna Dossing
38 min•20 juli 2025
Om avsnittet
Methotrexate is a well-established drug used in oncology, but could it also play a role in managing osteoarthritis? In this episode of Joint Action, Professor David Hunter is joined by Dr Anna Døssing and Professor Robin Christensen to explore the potential of methotrexate as a treatment for osteoarthritis pain.
They discuss:
- What methotrexate is and how it works
- Insights from a recent meta-analysis on its effectiveness and safety
- Why individual studies show mixed results
- Whether it might help people with hand or knee OA - especially those with signs of inflammation
- How dosing and side effects factor into clinical decision-making
Tune in for an honest, data-driven conversation about repurposing an old drug for a new purpose - and what it could mean for people living with osteoarthritis.
RESOURCES
- Editorial: Methotrexate for osteoarthritis—Ready for clinical use and in whom?: https://www.oarsijournal.com/article/S1063-4584(25)00973-2/abstract?
CONNECT WITH US
- Twitter: @ProfDavidHunter @jointactionorg
- Instagram: @osteoarthritisresearchgroup
- Email: [email protected]
- Website: https://www.jointaction.info/podcast
Hosted on Acast. See acast.com/privacy for more information.
Fler avsnitt
Visa alla avsnitt av Joint ActionJoint Action med David Hunter, PhD, FRACP (Rheum) finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.